Patient Enrolled at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital Aethlon's Trial is a Safety, Feasibility, and Dose Finding Study of the Hemopurifier® ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new study finds.

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Merck & Co’s attempts to move its checkpoint inhibitor Keytruda into prostate cancer have been blocked once again, continuing a run of disappointing studies with immunotherapies in the disease.

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Here's all you need to know about this deadly disease, from its causes to preventive measures: Cancer does not have a single cause; rather, it begins with damage to the genes that control how ...

Longtime research has shown that drinking fluoridated water at the recommended levels in the US is safe and beneficial for oral health ...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new s ...